Native arteriovenous fistula (AVF) is the favorite access for hemodialysis (HD). The National
Kidney Foundation's Kidney Disease Outcomes Quality Initiative (KDOQI) recommends its …

Purpose To use safety and efficacy outcomes following treatment with percutaneous
transluminal angioplasty (PTA) and/or stent placement for thoracic central venous …

Central venous stenosis (CVS) is encountered frequently among hemodialysis patients.
Prior ipsilateral central venous catheterization and cardiac rhythm device insertions are …

Background: Catheter-directed treatment is the standard approach for the management of
chronic central venous occlusion. Purpose: The objective of this study is to report the …

Central venous disease (CVD) with stenosis or occlusion is a severe and prevalent
complication for chronic hemodialysis (HD) patients, resulting in dialysis access dysfunction …

Purpose This prospective, observational first in human study evaluated the safety and
effectiveness of WRAPSODY TM Cell-impermeable Endoprosthesis (Merit Medical Systems …

Objective: The study purpose was to determine the outcomes and factors predictive of
primary stent patency for the treatment of central venous occlusive disease (CVOD) in …

Background Hemodialysis graft outflow stenosis is a significant complication occurring in
hemodialysis patients with prosthetic grafts for vascular access. Balloon angioplasty remains …

Purpose The purpose of this study was to compare the primary and secondary patency rates
of percutaneous transluminal angioplasty (PTA) alone with those of metallic stent placement …

Background It has not been demonstrated that computational fluid dynamics (CFD) can be
used to model central venous stenosis (CVS), nor that hemodynamic changes in CVS …